AGM/EGMMay 18, 2026, 04:37 PM
Alpha Tau Medical Schedules AGM for June 23, 2026; Key Director & CEO Votes
AI Summary
Alpha Tau Medical Ltd. announced its Annual General Meeting of Shareholders to be held on June 23, 2026, where shareholders will consider and vote on six key proposals. These include the re-election of two Class II directors, re-approval of the compensation policy, re-appointment of Uzi Sofer as CEO and Chairman, approval of his compensation, extension of certain options, and re-appointment of the independent auditor. The Board of Directors unanimously recommends voting "FOR" each of the proposals.
Key Highlights
- Annual General Meeting scheduled for June 23, 2026, at 4:00 p.m. Israel time.
- Shareholders to vote on re-electing David Milch and Ruth Alon as Class II directors until 2029.
- Proposals include re-approving the Compensation Policy for Executive Officers and Directors.
- Vote on re-appointing Uzi Sofer as CEO and Chairman, and approving his compensation package.
- Approval sought for the extension of terms of certain options for directors and officers.
- Re-appointment of Kost Forer Gabbay & Kasierer as independent auditor for 2026.
- Record date for voting is May 12, 2026, with 90,325,876 shares outstanding.
- Oramed Ltd. holds 18.9% and Uzi Sofer holds 15.8% of Alpha Tau Medical's shares.
Price Impact
More from DRTS